Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer

Journal of Surgical Oncology

Volumn 109, Issue 7, 2014, Pages 684-689

  Murai, Toshifumi ^a   Yamada, Suguru ^a   Fuchs, Bryan C ^b   Fujii, Tsutomu ^a   Nakayama, Goro ^a   Sugimoto, Hiroyuki ^a   Koike, Masahiko ^a   Fujiwara, Michitaka ^a   Tanabe, Kenneth K ^b   Kodera, Yasuhiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

epithelial to mesenchymal transition; gastric cancer; prognosis; Zeb 1

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER CELL LINE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; VERY ELDERLY; YOUNG ADULT;

EPITHELIAL-TO-MESENCHYMAL TRANSITION; GASTRIC CANCER; PROGNOSIS; ZEB-1;

ADULT; AGED; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84899581133     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23564     Document Type: Article

References (32)

1. Yang D, Hendifar A, Lenz C, et al.: Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity. J Gastrointest Oncol 2011; 2: 77-84.
2. Jemal A, Siegel R, Xu J, et al.: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
3. Thiery JP, Sleeman JP,: Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142.
4. Shook D, Keller R,: Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 2003; 120: 1351-1383.
5. Radisky DC,: Epithelial-mesenchymal transition. J Cell Sci 2005; 118: 4325-4326.
6. Thiery JP,: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740-746.
7. Yang J, Mani SA, Weinberg RA,: Exploring a new twist on tumor metastasis. Cancer Res 2006; 66: 4549-4552.
8. Jechlinger M, Grunert S, Tamir IH, et al.: Expression profiling of epithelial plasticity in tumor progression. Oncogene 2003; 22: 7155-7169.
9. Larue L, Bellacosa A,: Epithelial-mesenchymal transition in development and cancer: Role of phosphatidylinositol 3-² kinase/AKT pathways. Oncogene 2005; 24: 7443-7454.
10. Thiery JP,: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
11. Brabletz T, Jung A, Spaderna S, et al.: Opinion: Migrating cancer stem cells-An integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5: 744-749.
12. Gotzmann J, Mikula M, Eger A, et al.: Molecular aspects of epithelial cell plasticity: Implications for local tumor invasion and metastasis. Mutat Res 2004; 566: 9-20.
13. Lee JM, Dedhar S, Kalluri R, et al.: The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-981.
14. Yang J, Mani SA, Donaher JL, et al.: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-939.
15. Thiery JP, Acloque H, Huang RY, et al.: Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
16. Rosivatz E, Becker I, Specht K, et al.: Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 2002; 161: 1881-1891.
17. Castro Alves C, Rosivatz E, Schott C, et al.: Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol 2007; 211: 507-515.
18. Yang Z, Zhang X, Gang H, et al.: Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression. Biochem Biophys Res Commun 2007; 358: 925-930.
19. Okugawa Y, Toiyama Y, Tanaka K, et al.: Clinical significance of Zinc finger E-box binding homeobox 1 (ZEB1) in human gastric cancer. J Surg Oncol 2012; 106: 280-285.
20. Jia B, Liu H, Kong Q, et al.: Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma. Mol Cell Biochem 2012; 366: 223-229.
21. Yamada S, Fuchs BC, Fujii T, et al.: Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery 2013; 154: 946-954.
22. Ito T, Yamada S, Tanaka C, et al.: Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer. Ann Surg Oncol 2013. Epub ahead of print
23. Maitah MY, Ali S, Ahmad A, et al.: Up-regulation of sonic hedgehog contributes to TGF-beta1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS ONE 2011; 6: e16068.
24. Chung JH, Rho JK, Xu X, et al.: Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs. Lung Cancer 2011; 73: 176-182.
25. Endo K, Ueda T, Ueyama J, et al.: Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol 2000; 31: 558-565.
26. Gillett CE, Miles DW, Ryder K, et al.: Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. J Pathol 2001; 193: 433-441.
27. Shimamura T, Sakamoto M, Ino Y, et al.: Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: Relationship to e-cadherin expression. J Clin Oncol 2003; 21: 659-667.
28. Hong SM, Li A, Olino K, et al.: Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas. Mod Pathol 2011; 24: 1237-1247.
29. Al-Saad S, Al-Shibli K, Donnem T, et al.: The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. Br J Cancer 2008; 99: 1476-1483.
30. Liu LK, Jiang XY, Zhou XX, et al.: Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: Correlation with the clinicopathological features and patient outcome. Mod Pathol 2010; 23: 213-224.
31. Fuchs BC, Fujii T, Dorfman JD, et al.: Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 2008; 68: 2391-2399.
32. Takeyama Y, Sato M, Horio M, et al.: Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage- independent cell growth of lung cancer cells. Cancer Lett 2010; 296: 216-224.